Afon Technology’s non-invasive continuous glucose monitor can detect blood sugar levels, study confirms
A small Welsh company has successfully developed the world’s first non-invasive and wearable glucose sensor that can measure blood sugar levels without penetrating the skin, latest research proves.
Results of a clinical study to be published in the Journal of Diabetes Science and Technology has confirmed that Afon Technology’s innovative device in the guise of a watch can successfully read a person’s blood glucose levels without having to inject into the skin.
During the trial conducted in Germany, the team of researchers ran multiple tests using the Afon device, which is set to transform the lives of those living with diabetes.
Afon Technology’s CEO, Sabih Chaudhry said: “Our device will be a game-changer for those living with diabetes, as it provides a pain-free and convenient way to monitor their blood glucose levels.”
He added: “This innovation is a testament to the power of innovation and the incredible possibilities that arise when we push the boundaries of what is possible.”
“Our achievement is attributed to the tireless work and dedication of the team at Afon Technology, and we are excited to see the positive impact this device will have on the health and wellbeing of many individuals around the globe.”
The device is designed to alert the user when they have high and low glucose levels and will also help to monitor personalised health trends.
Companies like Apple, Samsung and Google are rumoured to have been trying to develop non-invasive blood glucose monitoring, but so far none have been successful. Afon Technology is one step closer to achieving this goal.
Founded in 2015 and based in Wales, Afon Technology has been awarded a number of grants for its work on this ground-breaking technology, most recently an Accelerator Grant for €2.4million from the European Innovation Council.
To access the study, click here.